Prudential Financial’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-37,311
Closed -$197K 2209
2025
Q3
$197K Buy
+37,311
New +$237K ﹤0.01% 2218
2021
Q1
Sell
-478
Closed -$19K 2484
2020
Q4
$19K Hold
478
﹤0.01% 2437
2020
Q3
$12K Sell
478
-46
-9% -$2.9K ﹤0.01% 2426
2020
Q2
$38K Buy
+524
New +$36.2K ﹤0.01% 2366

Other funds holding ABEO

Prudential Financial's ABEO Position: Q4 2025 in Review

Prudential Financial sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 37,311 shares — an estimated $197K sold.

Prudential Financial first reported a position in ABEO in Q2 2020 and held it in 4 quarters. The position peaked at $197K in Q3 2025. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Prudential Financial reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Prudential Financial sold 37,311 Abeona Therapeutics shares in Q4 2025, an estimated $197K.
  • Prudential Financial first reported a position in Abeona Therapeutics in Q2 2020 and held it in 4 quarters.
  • Prudential Financial's Abeona Therapeutics position peaked at $197K in Q3 2025.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Prudential Financial's 13F filing for Q4 2025, filed 13 Feb 2026.